Difference between revisions of "Spindle cell lesions"
Jump to navigation
Jump to search
m (→A long DDx of spindle cell tumour: change KS) |
|||
(23 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
'''[[Spindle cell]] lesions''' are seen frequent enough that one ought to have a solid approach to 'em. | [[Image:Malignant_peripheral_nerve_sheath_tumour_-_very_high_mag.jpg|thumb|right|250px|A spindle cell lesion ([[MPNST]]). [[H&E stain]].]] | ||
'''[[Spindle cell]] lesions''' are seen frequent enough that one ought to have a solid approach to 'em. | |||
A general introduction to ''spindle cells'' is found in the ''[[spindle cell]]'' article. | |||
==General DDx== | ==General DDx== | ||
Line 10: | Line 13: | ||
**Carcinoma, e.g. metaplastic carcinoma. | **Carcinoma, e.g. metaplastic carcinoma. | ||
===A long | ===A long differential diagnosis of spindle cell tumours=== | ||
Adapted from ''Miller'' with modifications:<ref name=miller>Miller RT. (Sep 2013). ''Atlantic Diagnostic Immunohistochemistry Symposium''. St. John's, NL, Canada.</ref> | |||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
! Tumour | |||
! Group | |||
! Notes/comments | |||
|- | |||
| [[Malignant melanoma]] | | [[Malignant melanoma]] | ||
| melanoma | | melanoma | ||
Line 24: | Line 32: | ||
| | | | ||
|- | |- | ||
| [[Desmoplastic | | [[Desmoplastic mesothelioma]] | ||
| carcinoma | | carcinoma | ||
| | | | ||
Line 36: | Line 44: | ||
| | | | ||
|- | |- | ||
| [[Malignant | | [[Malignant phyllodes tumour]] | ||
| sarcoma | | sarcoma | ||
| | | | ||
Line 44: | Line 52: | ||
| | | | ||
|- | |- | ||
| [[ | | [[Malignant mixed Muellerian tumour]] | ||
| carcinoma | | carcinoma | ||
| | | | ||
Line 218: | Line 226: | ||
| [[Sclerotic "plywood" fibroma]] | | [[Sclerotic "plywood" fibroma]] | ||
| fibroblastic/myofibroblastic tumours | | fibroblastic/myofibroblastic tumours | ||
| | | <ref>{{Cite journal | last1 = Hanft | first1 = VN. | last2 = Shea | first2 = CR. | last3 = McNutt | first3 = NS. | last4 = Pullitzer | first4 = D. | last5 = Horenstein | first5 = MG. | last6 = Prieto | first6 = VG. | title = Expression of CD34 in sclerotic ("plywood") fibromas. | journal = Am J Dermatopathol | volume = 22 | issue = 1 | pages = 17-21 | month = Feb | year = 2000 | doi = | PMID = 10698210 }}</ref> | ||
|- | |- | ||
| [[Fibrosarcoma]] | | [[Fibrosarcoma]] | ||
Line 274: | Line 282: | ||
| [[Myofibroblastoma]] | | [[Myofibroblastoma]] | ||
| fibroblastic/myofibroblastic tumours | | fibroblastic/myofibroblastic tumours | ||
| | | superficial cervicovaginal myofibroblastoma<ref name=pmid15693885>{{Cite journal | last1 = Ganesan | first1 = R. | last2 = McCluggage | first2 = WG. | last3 = Hirschowitz | first3 = L. | last4 = Rollason | first4 = TP. | title = Superficial myofibroblastoma of the lower female genital tract: report of a series including tumours with a vulval location. | journal = Histopathology | volume = 46 | issue = 2 | pages = 137-43 | month = Feb | year = 2005 | doi = 10.1111/j.1365-2559.2005.02063.x | PMID = 15693885 }}</ref> | ||
|- | |||
| | |||
| | |||
| | |||
|- | |- | ||
| [[Cellular Angiofibroma]] | | [[Cellular Angiofibroma]] | ||
Line 426: | Line 430: | ||
**[[Spindle cell squamous carcinoma]]. | **[[Spindle cell squamous carcinoma]]. | ||
*[[Malignant melanoma]]. | *[[Malignant melanoma]]. | ||
*Others - see ''[[pleomorphic tumours]]'' for an exhaustive DDx. | |||
===Grouping by pattern=== | ===Grouping by pattern=== | ||
Line 436: | Line 441: | ||
*Desmin. | *Desmin. | ||
*SMA. | *SMA. | ||
* | *[[S-100]]. | ||
*AE1/AE3 (pankeratin). | *[[AE1/AE3]] (pankeratin). | ||
Memory device ''SCADS'' or ''CAD SS'' = | Memory device ''SCADS'' or ''CAD SS'' = S-100, CD34, AE1/AE3, Desmin, SMA. | ||
===Big panels=== | ===Big panels=== | ||
====A MSH MFH panel==== | ====A MSH MFH panel==== | ||
*CD34 - [[GIST]], [[angiosarcoma]], [[solitary fibrous tumour]]/[[hemangiopericytoma]], [[Kaposi sarcoma]], [[DFSP]], [[PASH]]. | *CD34 - [[GIST]], [[angiosarcoma]], [[solitary fibrous tumour]]/[[hemangiopericytoma]], [[Kaposi sarcoma]], [[DFSP]], [[PASH]]. | ||
* | *S-100 - neural marker, sensitive for [[malignant melanoma]], Langerhans cells, [[clear cell sarcoma]]. | ||
*Desmin - smooth muscle. | *Desmin - smooth muscle. | ||
*MIB1 - proliferation. | *MIB1 - proliferation. | ||
Line 454: | Line 459: | ||
*Caldesmon - muscle. | *Caldesmon - muscle. | ||
*PDGFR - [[GIST]] | *PDGFR - [[GIST]] | ||
* | *[[DOG1]] - GIST (membranous, cytoplasmic),<ref name=pmid19417627>{{cite journal |author=Ardeleanu C, Arsene D, Hinescu M, ''et al.'' |title=Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker |journal=Appl. Immunohistochem. Mol. Morphol. |volume=17 |issue=5 |pages=413–8 |year=2009 |month=October |pmid=19417627 |doi=10.1097/PAI.0b013e31819e4dc5 |url=}}</ref> normal pancreas (islets),<ref name=pmid19417627/> associated with [[BRCA1]]. | ||
Others: | Others: | ||
Line 465: | Line 470: | ||
*Keratin 5D3 - carcinomas. | *Keratin 5D3 - carcinomas. | ||
*Keratin LP34 - carcinomas. | *Keratin LP34 - carcinomas. | ||
*EMA. | *[[EMA]]. | ||
*CD99. | *CD99. | ||
*MSA. | *MSA. | ||
Line 483: | Line 488: | ||
*CD30. | *CD30. | ||
*CD3. | *CD3. | ||
*CD20. | *[[CD20]]. | ||
*Desmin. | *Desmin. | ||
*CD31 - [[angiosarcoma]]. | *CD31 - [[angiosarcoma]]. | ||
Line 496: | Line 501: | ||
*[[Spindle cell]]. | *[[Spindle cell]]. | ||
*[[Epithelioid cell lesions]]. | *[[Epithelioid cell lesions]]. | ||
*[[Spindle cell lesions of the skin]]. | |||
==Treatment== | ==Treatment== |
Latest revision as of 15:44, 18 June 2017
Spindle cell lesions are seen frequent enough that one ought to have a solid approach to 'em.
A general introduction to spindle cells is found in the spindle cell article.
General DDx
Spindle cells should make think:
- Nerve.
- Muscle.
- Smooth.
- Skeletal.
- Other.
- Carcinoma, e.g. metaplastic carcinoma.
A long differential diagnosis of spindle cell tumours
Adapted from Miller with modifications:[1]
Microscopic
Grouping by pleomorphism
- Monomorphic - small variation of tumour cell size.
- Pleomorphic - large variation of tumour cell size.
DDx - monomorphic:
- Synovial sarcoma.
- Fibrosarcoma.
- MPNST.
- Metaplastic carcinoma, e.g. metaplastic breast carcinoma.
DDx - pleomorphic:
- Pleomorphic undifferentiated sarcoma.
- Pleomorphic liposarcoma.
- Pleomorphic rhabdomyosarcoma.
- Pleomorphic leiomyosarcoma.
- Metaplastic carcinoma.
- Malignant melanoma.
- Others - see pleomorphic tumours for an exhaustive DDx.
Grouping by pattern
IHC
Basic panel
Dixon panel:[11]
Memory device SCADS or CAD SS = S-100, CD34, AE1/AE3, Desmin, SMA.
Big panels
A MSH MFH panel
- CD34 - GIST, angiosarcoma, solitary fibrous tumour/hemangiopericytoma, Kaposi sarcoma, DFSP, PASH.
- S-100 - neural marker, sensitive for malignant melanoma, Langerhans cells, clear cell sarcoma.
- Desmin - smooth muscle.
- MIB1 - proliferation.
- CD99 - immature T cells (thymus), small round cell tumours, synovial sarcoma, Merkel cell carcinoma, osteosarcoma.[12]
- Considered "slutty", i.e. non-specific, by Dr. Fletcher; useful if membranous stain pattern = Ewing sarcoma/PNET.
- BCL2 - synovial sarcoma, small cell lymphomas, spindle cell lipoma,[13][14] solitary fibrous tumour.
- PGP 9.5.
- SMMS - smooth muscle.
- Caldesmon - muscle.
- PDGFR - GIST
- DOG1 - GIST (membranous, cytoplasmic),[15] normal pancreas (islets),[15] associated with BRCA1.
Others:
- Beta-catenin - a small subset of soft tissue lesions:
- Desmoid-type fibromatosis (~70%), solitary fibrous tumour & endometrial stromal sarcoma (~40%), synovial sarcoma (~30%).[16]
DJH panels
MFH
- Vimentin.
- Keratin 5D3 - carcinomas.
- Keratin LP34 - carcinomas.
- EMA.
- CD99.
- MSA.
- SMA.
- Caldesmon.
- CD34.
- S-100 - neural tumours.
- HMB45 - melanoma
- Mart-1 - melanoma.
- Tyrosinase.
- MYF-4 - RMS.
- Alpha-1-antichymotrypsin.
SRCT
Same as MFH panel plus the following:
- CD45.
- CD30.
- CD3.
- CD20.
- Desmin.
- CD31 - angiosarcoma.
- Factor VIII - angiosarcoma.
See also
- Bone.
- Dermatopathology.
- Hematopathology.
- Soft tissue lesions.
- Immunohistochemistry.
- Spindle cell.
- Epithelioid cell lesions.
- Spindle cell lesions of the skin.
Treatment
- It depends on the subtype.
- Malignant lesions are usually sarcomas and treated with radiation and surgery.[17]
References
- ↑ Miller RT. (Sep 2013). Atlantic Diagnostic Immunohistochemistry Symposium. St. John's, NL, Canada.
- ↑ Remstein, ED.; Kurtin, PJ.; Nascimento, AG. (Jan 2000). "Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders.". Am J Surg Pathol 24 (1): 51-5. PMID 10632487.
- ↑ Dei Tos, AP.; Mentzel, T.; Newman, PL.; Fletcher, CD. (Sep 1994). "Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma. Analysis of six cases.". Am J Surg Pathol 18 (9): 913-21. PMID 8067512.
- ↑ Folpe, AL.; Weiss, SW. (Jun 2002). "Lipoleiomyosarcoma (well-differentiated liposarcoma with leiomyosarcomatous differentiation): a clinicopathologic study of nine cases including one with dedifferentiation.". Am J Surg Pathol 26 (6): 742-9. PMID 12023578.
- ↑ Hanft, VN.; Shea, CR.; McNutt, NS.; Pullitzer, D.; Horenstein, MG.; Prieto, VG. (Feb 2000). "Expression of CD34 in sclerotic ("plywood") fibromas.". Am J Dermatopathol 22 (1): 17-21. PMID 10698210.
- ↑ Montgomery, E.; Goldblum, JR.; Fisher, C. (Feb 2001). "Myofibrosarcoma: a clinicopathologic study.". Am J Surg Pathol 25 (2): 219-28. PMID 11176071.
- ↑ Ganesan, R.; McCluggage, WG.; Hirschowitz, L.; Rollason, TP. (Feb 2005). "Superficial myofibroblastoma of the lower female genital tract: report of a series including tumours with a vulval location.". Histopathology 46 (2): 137-43. doi:10.1111/j.1365-2559.2005.02063.x. PMID 15693885.
- ↑ Iwasa, Y.; Fletcher, CD. (Nov 2004). "Cellular angiofibroma: clinicopathologic and immunohistochemical analysis of 51 cases.". Am J Surg Pathol 28 (11): 1426-35. PMID 15489646.
- ↑ Oliva, E.; Clement, PB.; Young, RH.; Scully, RE. (Aug 1998). "Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases.". Am J Surg Pathol 22 (8): 997-1005. PMID 9706980.
- ↑ Ulbright, TM.; Srigley, JR.; Hatzianastassiou, DK.; Young, RH. (Nov 2002). "Leydig cell tumors of the testis with unusual features: adipose differentiation, calcification with ossification, and spindle-shaped tumor cells.". Am J Surg Pathol 26 (11): 1424-33. PMID 12409718.
- ↑ BD. 1 April 2011.
- ↑ Tadrous, Paul.J. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum (1st ed.). Wiley. pp. 108. ISBN 978-0470519035.
- ↑ Tadrous, Paul.J. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum (1st ed.). Wiley. pp. 107. ISBN 978-0470519035.
- ↑ URL: http://ajp.amjpathol.org/cgi/content/full/160/3/759. Accessed on: 3 August 2010.
- ↑ 15.0 15.1 Ardeleanu C, Arsene D, Hinescu M, et al. (October 2009). "Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker". Appl. Immunohistochem. Mol. Morphol. 17 (5): 413–8. doi:10.1097/PAI.0b013e31819e4dc5. PMID 19417627.
- ↑ Ng TL, Gown AM, Barry TS, et al. (January 2005). "Nuclear beta-catenin in mesenchymal tumors". Mod. Pathol. 18 (1): 68–74. doi:10.1038/modpathol.3800272. PMID 15375433.
- ↑ Collini P, Sorensen PH, Patel S, et al. (August 2009). "Sarcomas with spindle cell morphology". Semin. Oncol. 36 (4): 324–37. doi:10.1053/j.seminoncol.2009.06.007. PMID 19664493.